Showing results (2141-2150 of 2,371) with videos related to

Sort By:
Pageof 238
Future Medicinal Chemistry|August 28, 2014
Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenograftsMarta Celegato, Dolores Fregona, Maurizio Mongiat, et al.
Future Medicinal Chemistry|August 28, 2014
The essential roles of chemistry in high-throughput screening triageJayme L Dahlin, Michael A Walters
Future Medicinal Chemistry|August 28, 2014
Activators of AMPK: not just for type II diabetesIlana Zaks, Tamar Getter, Arie Gruzman
Future Medicinal Chemistry|July 25, 2022
Identification of dual-targeted Mycobacterium tuberculosis aminoacyl-tRNA synthetase inhibitors using machine learningGalyna P Volynets, Mariia O Usenko, Olga I Gudzera, et al.
Future Medicinal Chemistry|January 26, 2016
Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?Chiara Nardon, Leonardo Brustolin, Dolores Fregona
Future Medicinal Chemistry|December 23, 2015
Bioactive isoquinolinequinone alkaloids from the South China Sea nudibranch Jorunna funebris and its sponge-prey Xestospongia spRen-Yong Huang, Wen-Ting Chen, Tibor Kurtán, et al.
Future Medicinal Chemistry|December 23, 2015
Why (multi)targeting of cyclin-dependent kinases is a promising therapeutic option for hormone-positive breast cancer and beyondJózefa Węsierska-Gądek, Matthias Mauritz
Future Medicinal Chemistry|December 25, 2015
Discovery of bicyclic inhibitors against menaquinone biosynthesisSeoung-ryoung Choi, Marilynn A Larson, Steven H Hinrichs, et al.
Future Medicinal Chemistry|February 13, 2016
SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitorsSheng Tang, Yu-Huan Li, Xin-Yue Cheng, et al.
Future Medicinal Chemistry|December 16, 2014
Targeting SH2 domains in breast cancerPietro Morlacchi, Fredika M Robertson, Jim Klostergaard, et al.
Pageof 238